Histogen (HSTO, $0.22) was a top loser this month, diving -3 to $0.22 per share. Of the 879 stocks analyzed in the Biotechnology Industry throughout this month, of them (6) exhibited an Uptrend while of them (3) were in a Downtrend.
a company, which engages in the development of patented, innovative technologies that replace and regenerate tissues in the body for the aesthetic and therapeutic markets